Director, Global Commercial Product Strategy

About Acadia Pharmaceuticals Acadia is committed to turning scientific promise into meaningful innovation that makes the difference for underserved neurological and rare disease communities around the world. Our commercial portfolio includes the first and only FDA-approved treatments for Parkinson’s disease psychosis and Rett syndrome. We are developing the next wave of therapeutic advancements with a robust and diverse pipeline that includes mid- to late-stage programs in Alzheimer’s disease psychosis and Lewy body dementia psychosis, along with earlier-stage programs that address other underserved patient needs. At Acadia, we’re here to be their difference. Please note that this position is based in San Diego, CA or San Francisco, CA. Acadia's hybrid model requires this role to work in our office three days per week on average. The Director, Global Commercial Product Strategy is responsible for shaping the commercial product strategy across the product lifecycle, from early development through launch and lifecycle optimization. Leads the cross functional Global Commercialization Team to develop the strategy and strategic plan for product commercialization across markets, inclusive of scenario planning, forecasting, and lifecycle planning. Serves as the commercial voice within the cross-functional Asset Strategy Team, ensuring pipeline assets are positioned for maximum value creation through data-driven insights, robust market understanding, and competitive differentiation. Primary Responsibilities: Lead end-to-end commercial strategic planning, inclusive of scenario planning, for assigned pipeline asset/s, through early development to launch readiness and commercialization. Develop target market analysis to determine current and future treatment paradigms, competitive landscape, unmet need, product positioning and value proposition. Drive development and updates to the Target Product Profile (TPP) in conjunction with program teams to shape clinical, HEOR, evidence